TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bristol-Myers Squibb Norway AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
200,872
|
157,484
|
507,055 |
| Financial expenses |
372
|
495
|
1,287 |
| Earnings before taxes |
9,890
|
7,976
|
23,686 |
| Total assets |
268,052
|
251,702
|
281,224 |
| Current assets |
267,709
|
251,553
|
281,029 |
| Current liabilities |
59,384
|
51,705
|
88,096 |
| Equity capital |
208,668
|
199,997
|
193,128 |
| - share capital |
1,000
|
800
|
800 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
77.8%
|
79.5%
|
68.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.9%
|
5.1%
|
4.7% |
| Return on assets (ROA) |
3.8%
|
3.4%
|
8.9% |
| Current ratio |
450.8%
|
486.5%
|
319.0% |
| Return on equity (ROE) |
4.7%
|
4.0%
|
12.3% |
| Change turnover |
43,388
|
-349,571
|
23,918 |
| Change turnover % |
28%
|
-69%
|
5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.